Boguniewicz M - Search Results

1

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, Weisman J, Lockshin B, Hultsch T, Zhang Q, Kamal MA, Davis JD, Akinlade B, Staudinger H, Hamilton JD, Graham NMH, Pirozzi G, Gadkari A, Eckert L, Stahl N, Yancopoulos GD, Ruddy M, Bansal A. Simpson EL, et al. Among authors: boguniewicz m. JAMA Dermatol. 2020 Jan 1;156(1):44-56. doi: 10.1001/jamadermatol.2019.3336. JAMA Dermatol. 2020. PMID: 31693077 Free PMC article. Clinical Trial.

2

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.

Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM. Boguniewicz M, et al. J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):637-44. doi: 10.1016/s0091-6749(98)70281-7. J Allergy Clin Immunol. 1998. PMID: 9802373 Clinical Trial.

3

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, Bush C, Graeber M. Eichenfield LF, et al. Among authors: boguniewicz m. J Am Acad Dermatol. 2002 Apr;46(4):495-504. doi: 10.1067/mjd.2002.122187. J Am Acad Dermatol. 2002. PMID: 11907497 Clinical Trial.

4

Combination therapy and new directions for managing atopic dermatitis.

Boguniewicz M. Boguniewicz M. Allergy Asthma Proc. 2002 Jul-Aug;23(4):243-6. Allergy Asthma Proc. 2002. PMID: 12221893 Review.

5

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.

Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Paller AS, Stevens SR, Whitaker-Worth DL, Tong KB. Ellis CN, et al. Among authors: boguniewicz m. J Am Acad Dermatol. 2003 Apr;48(4):553-63. doi: 10.1067/mjd.2003.240. J Am Acad Dermatol. 2003. PMID: 12664019

6

Treatment options and new therapeutic approaches in atopic dermatitis.

Boguniewicz M. Boguniewicz M. Dermatol Nurs. 2003 Aug;Suppl:12-8. Dermatol Nurs. 2003. PMID: 14520893 Review.

7

Current management of atopic dermatitis and interruption of the atopic march.

Boguniewicz M, Eichenfield LF, Hultsch T. Boguniewicz M, et al. J Allergy Clin Immunol. 2003 Dec;112(6 Suppl):S140-50. doi: 10.1016/j.jaci.2003.09.031. J Allergy Clin Immunol. 2003. PMID: 14657844 Review.

8

New insights into atopic dermatitis.

Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. Leung DY, et al. Among authors: boguniewicz m. J Clin Invest. 2004 Mar;113(5):651-7. doi: 10.1172/JCI21060. J Clin Invest. 2004. PMID: 14991059 Free PMC article. Review.

9

A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis.

Kempers S, Boguniewicz M, Carter E, Jarratt M, Pariser D, Stewart D, Stiller M, Tschen E, Chon K, Wisseh S, Abrams B. Kempers S, et al. Among authors: boguniewicz m. J Am Acad Dermatol. 2004 Oct;51(4):515-25. doi: 10.1016/j.jaad.2004.01.051. J Am Acad Dermatol. 2004. PMID: 15389185 Clinical Trial.

10

The economics of topical immunomodulators for the treatment of atopic dermatitis.

Abramovits W, Boguniewicz M, Paller AS, Whitaker-Worth DL, Prendergast MM, Tokar M, Tong KB. Abramovits W, et al. Among authors: boguniewicz m. Pharmacoeconomics. 2005;23(6):543-66. doi: 10.2165/00019053-200523060-00003. Pharmacoeconomics. 2005. PMID: 15960552 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page